ImpediMed is pleased to announce the commencement of product launch activities by one of its distributors, Lymphedema Products, LLC who are launching ImpediMed’s first US FDA cleared medical device, the XCA, for use in the clinical assessment of lymphedema among breast cancer survivors. Read more